(Q33489520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

review article

1 reference

title

Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 December 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

445-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7727054%20AND%20SRC:MED&resulttype=core&format=json

Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia

24 October 2019

cites work

1 reference

12 December 2020

Polypharmacy in fatal clozapine-associated agranulocytosis

1 reference

12 December 2020

Mechanism of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes

1 reference

12 December 2020

Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes

1 reference

12 December 2020

Quinine-induced disseminated intravascular coagulation

1 reference

12 December 2020

Treatment of Idiopathic Neutropenia in the Elderly with Recombinant Human Granulocyte Colony-Stimulating Factor

1 reference

12 December 2020

Drug-Induced Neutropenia in the Stockholm Region 1973-75: Frequency and Causes

1 reference

12 December 2020

Gold-induced thrombocytopenia. A clinical and immunogenetic study of twenty-three patients

1 reference

12 December 2020

Incidence of aplastic anemia in a three county area in South Carolina.

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Heparin-associated thrombocytopenia.

1 reference

12 December 2020

Drug-induced agranulocytosis: experience in two university hospitals

1 reference

12 December 2020

Aplastic anemia due to gold therapy unsuccessfully treated with BAL

1 reference

12 December 2020

Studies on agranulocytosis. IV. Effects of chlorpromazine on nucleic acid synthesis of bone marrow cells in vitro

1 reference

12 December 2020

Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics

1 reference

12 December 2020

Drug-induced agranulocytosis

1 reference

12 December 2020

Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia

1 reference

12 December 2020

Fatal acute immune haemolytic anaemia caused by nalidixic acid

1 reference

12 December 2020

Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease

1 reference

12 December 2020

Iatrogenic illness on a general medical service at a university hospital

1 reference

12 December 2020

Studies on agranulocytosis. IX. A biochemical defect in chlorpromazine-sensitive marrow cells

1 reference

12 December 2020

Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee

1 reference

12 December 2020

Adverse-drug-reaction monitoring

1 reference

12 December 2020

Immune hemolytic anemia associated with sulindac

1 reference

12 December 2020

Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application

1 reference

12 December 2020

A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis

1 reference

12 December 2020

Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms

1 reference

12 December 2020

Agranulocytosis during treatment with chlozapine

1 reference

12 December 2020

Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors

1 reference

12 December 2020

Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF)

1 reference

12 December 2020

Regulation of hematopoiesis

1 reference

12 December 2020

The importance of adverse reactions in drug regulation

1 reference

12 December 2020

Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity

1 reference

12 December 2020

Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force

1 reference

12 December 2020

Granulocyte-Colony Stimulating Factor Therapy in Drug-Induced Agranulocytosis

1 reference

12 December 2020

Very low doses of GM-CSF administered alone or with erythropoietin in a plastic anemia

1 reference

12 December 2020

Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias

1 reference

12 December 2020

Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study

1 reference

12 December 2020

A population study of severe aplastic anemia in children. Incidence, etiology and course

1 reference

12 December 2020

Drug-induced neutropenia due to direct effects on CFU-C--ten years of culture experience

1 reference

12 December 2020

Human haemopoietic stem cell assays

1 reference

12 December 2020

N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis.

1 reference

12 December 2020

Multidisciplinary program for detecting and evaluating adverse drug reactions.

1 reference

12 December 2020

Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Drug-induced agranulocytosis. II. The role of medication in a food outcome

1 reference

12 December 2020

Myelotoxicity of gold

1 reference

12 December 2020

Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis

1 reference

12 December 2020

Fatal immune hemolytic anemia due to cefotetan

1 reference

12 December 2020

Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia

1 reference

12 December 2020

Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia.

1 reference

12 December 2020

Drug-induced Immune Thrombocytopenia

1 reference

12 December 2020

Incidence and etiology of aplastic anemia in a defined population of Argentina (1966-1977)

1 reference

12 December 2020

Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

12 December 2020

Treatment of drug-induced agranulocytosis with granulocyte-colony stimulating factor

1 reference

12 December 2020

How should we monitor gold therapy?

1 reference

12 December 2020

Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone

1 reference

12 December 2020

A diagnostic test for heparin-induced thrombocytopenia

1 reference

12 December 2020

Quality criteria for early signals of possible adverse drug reactions

1 reference

12 December 2020

Fatal quinine-induced thrombocytopenia

1 reference

12 December 2020

Drug-induced neutropenia--a survey for Stockholm 1973-1978.

1 reference

12 December 2020

Aplastic anaemia incidence in parts of the United Kingdom in 1985

1 reference

12 December 2020

Laboratory investigation of drug-induced immune thrombocytopenias.

1 reference

12 December 2020

Immune drug-induced haemolytic anemias

1 reference

12 December 2020

Clozapine: progress in treating refractory schizophrenia

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Gold-associated thrombocytopenia. Report six cases

1 reference

12 December 2020

Hospital admissions caused by iatrogenic disease

1 reference

12 December 2020

Drug-induced Blood Dyscrasias in Sweden

1 reference

12 December 2020

Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Aplastic anaemia in the Northern Region 1971-1978 and follow-up of long term survivors

1 reference

12 December 2020

The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Amrinone-associated thrombocytopenia: pharmacokinetic analysis

1 reference

12 December 2020

Captopril-associated neutropenia. Who is at risk?

1 reference

12 December 2020

Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor

1 reference

12 December 2020

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome

1 reference

12 December 2020

A method for estimating the probability of adverse drug reactions

1 reference

12 December 2020

Drug-induced oxidative haemolysis.

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use

1 reference

12 December 2020

Drug-induced autoimmune hemolytic anemia.

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Drug-Induced Neutropenias in the Stockholm Region 1976-1977

1 reference

12 December 2020

The human hematopoietic colony-stimulating factors

1 reference

12 December 2020

Drug-induced immune hemolytic anemia

1 reference

12 December 2020

GM-CSF therapy for drug-induced agranulocytosis

1 reference

12 December 2020

Drugs and the bone marrow

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.

1 reference

12 December 2020

Treatment of gold-induced aplastic anaemia with immunosuppressive therapy

1 reference

12 December 2020

Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies

1 reference

12 December 2020

ACCELERATED RECOVERY FROM DRUG-INDUCED AGRANULOCYTOSIS FOLLOWING G-CSF THERAPY

1 reference

12 December 2020

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

1 reference

12 December 2020

Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia

1 reference

12 December 2020

Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis

1 reference

12 December 2020

Gold induced aplastic anemia. Complete response to corticosteroids, plasmapheresis, and N-acetylcysteine infusion.

1 reference

12 December 2020

Intravenous Immune Globulin for the Treatment of Presumed Quinidine-Induced Thrombocytopenia

1 reference

12 December 2020

Haematological aspects of drug-induced agranulocytosis

1 reference

12 December 2020

Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis

1 reference

12 December 2020

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

1 reference

12 December 2020

Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group.

1 reference

12 December 2020

First use of G-CSF in chlorpromazine-induced agranulocytosis: a report of two cases

1 reference

12 December 2020

Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril

1 reference

12 December 2020

Colony-stimulating factor and drug-induced agranulocytosis

1 reference

12 December 2020

Agranulocytosis: a report of 30 cases

1 reference

12 December 2020

Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis

1 reference

12 December 2020

Drug-induced immune neutropenia.

1 reference

12 December 2020

Incidence of aplastic anemia in metropolitan Baltimore: a population-based study

1 reference

12 December 2020

Agranulocytosis following administration of phenothiazine derivatives

1 reference

12 December 2020